Saturday, 16 January 2021

"iLAB will allow for COVID-19 testing access to thousands of patients in remote areas"- Ravi Kaushik

02 July 2020 | Views

Ravi Kaushik, CEO, Transasia Bio-Medicals, Mumbai talks about the company's recent contribution in the fights against COVID-19

Image Credit: linkedin

Image Credit: linkedin

"We are glad and proud to be the technology partner of choice for AMTZ and Department of Biotechnology, GoI and to extend our technical and clinical expertise in developing an innovative 'lab on wheels' in the nation's mission to fight against COVID-19. This collaboration with GoI builds on Transasia's 41-years-old legacy of providing high quality products at affordable cost across the heartland of India.

Named Infectious Disease Diagnostic Lab (iLAB), this state-of-the-art mobile microbial containment (BSL-2) laboratory was made in Transasia's Vizag manufacturing facility at AMTZ, Asia's first medical device manufacturing park at Vishakhapatnam in partnership with Bharat Benz and support of Department of Biotechnology (DBT) Government of India.

We take pride in driving this idea from concept to reality, working closely with AMTZ. The iLAB will allow for COVID-19 testing access to thousands of patients in remote areas who would otherwise find it difficult to reach a lab and get a test done. It goes beyond free testing by providing diagnosis at the doorstep of needy patients.” 

- Ravi Kaushik, CEO, Transasia Bio-Medicals, Mumbai


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls